The DOI matches its Crossref record; 177 of the 179 references it cites were found in a registry or an index.
Focusing on claudin-5: A promising candidate in the regulation of BBB to treat ischemic stroke
Abstract
Claudin-5 is a tight junction (TJ) protein in the blood-brain barrier (BBB) that has recently attracted increased attention. Numerous studies have demonstrated that claudin-5 regulates the integrity and permeability of the BBB. Increased claudin-5 expression plays a neuroprotective role in neurological diseases, particularly in cerebral ischemic stroke. Moreover, claudin-5 might be a potential marker for early hemorrhagic transformation detection in ischemic stroke. In light of the distinctive effects of claudin-5 on the nervous system, we present the elaborate network of roles that claudin-5 plays in ischemic stroke. In this review, we first introduce basic knowledge regarding the BBB and the claudin family, the characterization and regulation of claudin-5, and association between claudin-5 and other TJ proteins. Subsequently, we describe BBB dysfunction and neuron-specific drivers of pathogenesis of ischemic stroke, including inflammatory disequilibrium and oxidative stress. Furthermore, we summarize promising ischemic stroke treatments that target the BBB via claudin-5, including modified rt-PA therapy, pharmacotherapy, hormone treatment, receptor-targeted therapy, gene therapy, and physical therapy. This review highlights recent advances and provides a comprehensive summary of claudin-5 in the regulation of the BBB and may be helpful for drug design and clinical therapy for treatment of ischemic stroke.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Astrocytic processes surround most of the vascular surface, regulating the blood–brain barrier (BBB) permeability [6, 7, 8, 9]—by modulating tight junction proteins such as claudin‐5 [10], or endothelial proteins such vimentin, which is associated with the stability of cerebral vasculature [11]—and integrate neuronal activity with blood flow [1, 2, 3, 4, 5, 12, 13, 14, 15, 16, 17, 18, 19, 20].”
From Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotection (2023) · cites this paper as [10]
In the citing paper
“claudin‐5 is crucial for the selective permeability of the BBB [10]”
From Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotection (2023) · cites this paper as [10]
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
JUNCTIONAL COMPLEXES IN VARIOUS EPITHELIA
Farquhar, M. G., & Palade, G. E. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.2.375 · Cited by 3,637
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917
Establishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
Claudins and the Modulation of Tight Junction Permeability
Günzel, D., & Yu, A. S. L. (2013) · Physiological Reviews · doi:10.1152/physrev.00019.2012 · Cited by 1,456
Nielsen, S. M., Nagelhus, E. A., Amiry-Moghaddam, M. R., Bourque, C. W., Agre, P. C., & Ottersen, O. P. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00171.1997 · Cited by 1,440
Cited by
Sorted by citations
Items 101–148 of 148
Poster Viewing Sessions PB01-B01 to PB03-V09
Badji, A., de la Colina, A. N., Sabra, D., Karakuzu, A., Bherer, L., Lamarre-Cliche, M., Stikov, N., Gauthier, C. J., Cohen‐Adad, J., & Girouard, H. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19851020 · Cited by 8
The protective effects of Pimavanserin against cerebral ischemia-induced brain injury
Li, X., & Tian, X. (2021) · Bioengineered · doi:10.1080/21655979.2021.1978617 · Cited by 7
Lin, P., Tan, R., Yu, P., Li, Y., Mo, Y., Li, W., & Zhang, J. (2022) · FEBS Letters · doi:10.1002/1873-3468.14315 · Cited by 7
Schindler, K. A., Torices, S., Schurhoff, N. A., Gallo, D. I., & Toborek, M. J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115645 · Cited by 8
Li, Z., Ji, X., Wang, X., Wang, J., Lin, R., Ma, X., Zhang, Q., & Shengxiang, L. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111599 · Cited by 5
Harmine-induced disruption of the blood-brain barrier via excessive mitophagy in zebrafish
Wu, Y., He, M., He, Y., Jin, T., Li, S., & He, F. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177223 · Cited by 5
Matsuzaki, H., Kai, K., Komohara, Y., Yano, H., Pan, C., Fujiwara, Y., Yamada, R., Iwauchi, A., Fukasawa, N., Tanaka, T., et al. (2025) · Cancer Science · doi:10.1111/cas.70014 · Cited by 5
Investigation of Poststroke Depression Following a Nucleus Accumbens Infarct in Mice
Bouchard, J., Daigle, B., Collignon, A., St-Arnault, V., Binder, L. B., Bevilacqua, L. M., Rioux, V., Dion‐Albert, L., Lebel, M., Lévesque, M., et al. (2025) · Stroke · doi:10.1161/strokeaha.125.050839 · Cited by 6
Oxytocin seals the blood–brain barrier, improving 22q11.2 deletion syndrome trajectories
Castellani, G., Ciampoli, M., Benedetti, A., Ferretti, V., Trigilio, G., Barcik, W., Busnelli, M., Contarini, G., Paolini, C., Devroye, C., et al. (2025) · Brain · doi:10.1093/brain/awaf112 · Cited by 6
Zhang, B., Zhang, S., Guo, Z., Hong, C., Zhang, F., & Lin, H. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03528-8 · Cited by 5
Tong, Y.-X., Zhu, S., Wang, Z., Zhao, Y.-X., Saleem, M. A. U., Malhi, K. K., Li, X., & Li, J. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c01703 · Cited by 6
Lozano-López, D. A., Hernández‐Ortega, L. D., González‐Mariscal, L., Díaz-Coránguez, M., Pinto-Dueñas, D. C., & Castañeda‐Arellano, R. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04956-9 · Cited by 6
Lin, Q., Wang, W., Yang, L., & Duan, X. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9684 · Cited by 5
Wei, X., Wen, Y., Hu, Y., & Guo, X. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230509113912 · Cited by 5
Klecker, P. H., Fritzen, L., Mazura, A. D., Weggen, S., & Pietrzik, C. U. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30431 · Cited by 5
Luteolin-borneol complex, a novel pharmaceutical preparation for aquaculture against NNV infection
Zhou, J.-L., Liu, X., Liu, Q.-X., Liu, T., Liu, T., Li, P., Ling, F., & Wang, G. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.741668 · Cited by 4
Li, J., Yu, J., Sun, T., Fan, M., Liu, Q., Li, X. L., Du, Y., Zhang, M., Wang, B., & Yang, Q. (2026) · Phytotherapy Research · doi:10.1002/ptr.70121 · Cited by 3
Shi, Z., Wang, J., Liu, K., Ma, F., & Du, H. (2026) · Pharmaceuticals · doi:10.3390/ph19030438 · Cited by 3
Chen, Z., Gong, X., & Lei, J. (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2022.100073 · Cited by 3
Immunohistochemical Analysis of Tight Junction Proteins
Greene, C., & Campbell, M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2289-6_18 · Cited by 3
Wu, X., Wang, L., Wang, K., Jia, K., Li, S., Meng, T., Yuan, H., Zhang, Q., & Hu, F. (2022) · Nano Research · doi:10.1007/s12274-022-4857-6 · Cited by 3
Chen, W.-Q., Du, W., & Yu, W. (2022) · Research Square · doi:10.21203/rs.3.rs-1257036/v1 · Cited by 3
Guhong injection attenuates brain injury and promotes neuroprotection after acute ischemic stroke
Du, X., Qi, Z., Li, Y., Wu, S., Zhang, F., Li, Z., & Chen, J. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578515 · Cited by 2
Oligodendrocyte precursor cell transplantation attenuates inflammation after ischemic stroke in mice
Wang, L.-P., Liu, C., Ma, Y., Yan, A., Yang, G., Qu, X., & Wei, W. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1583982 · Cited by 2
Ebrahimi‐Dehkordi, S., Anjomshoa, M., Ghasemi, S., Saghaei, E., Boroujeni, S. N., & Amini-Khoei, H. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70008 · Cited by 2
Boichuk, S., Bikinieva, F., & Kopnin, P. (2024) · Russian Journal of Oncology · doi:10.17816/onco636917 · Cited by 2
Low-pressure exposure influences the development of HAPE
Wang, B., Hou, J., Li, J., Pei, S., Xie, K., & Liu, W. X. (2025) · Open Life Sciences · doi:10.1515/biol-2022-1029 · Cited by 2
Inhibition of Salvianolic Acid B and Ginsenoside Rg1 on Hemorrhagic Transformation after Stroke
Xing, R., Wang, Y., Wang, L., Shen, H., Jin, Y., Yu, H., Liu, R., & Jiang, B. (2023) · Chinese medicine and natural products · doi:10.1055/s-0043-1770074 · Cited by 2
Construction and Functional Evaluation of 2D and 3D Human Blood–Brain Barrier Models
Kurosawa, T., Kubo, Y., & Deguchi, Y. (2025) · Current human cell research and applications · doi:10.1007/978-981-97-9495-9_14 · Cited by 1
Cheng, C., Xiong, D., Zheng, F., Wang, T., & Li, W. (2025) · NeuroToxicology · doi:10.1016/j.neuro.2025.07.008 · Cited by 1
Stewart, W. B., Jr., Hejl, C., Guleria, R. S., & Gupta, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-28435-2 · Cited by 1
Effects of prolonged fixation on vascular biomarkers in postmortem human brains
Frigon, É., Ma, W., Tremblay, C., Mirault, D., Turecki, G., Mechawar, N., Boire, D., Maranzano, J., Dadar, M., & Zeighami, Y. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261461536 · Cited by 2
Stanworth, M., & Zhang, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313139 · Cited by 1
Overcoming Barriers to Improve Treatments in Epilepsy
Wong, J. C. (2022) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597221127164 · Cited by 1
Almusined, M. M., Kakkar, P., Yuldasheva, N. Y., Viswambharan, H., Kakkar, T., & Saha, S. (2023) · Preprints.org · doi:10.20944/preprints202309.1491.v1 · Cited by 1
Vascular-Related Biomarkers of Ischemic Stroke
Arteaga, D., & Worrall, B. B. (2019) · Neuromethods · doi:10.1007/978-1-4939-9682-7_2
Sakaue, T., Fujishima, Y., Fukushima, Y., Tsugawa-Shimizu, Y., Fukuda, S., Kita, S., Nishizawa, H., Ranscht, B., Nishida, K., Maeda, N., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1048571/v1
Jufri, N. F., Salyam, T., Ibrahim, F. W., Yoganathan, D., Hamid, A., Latif, M. A., Saleh, S. N. M., & Juhari, N. A. S. (2023) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2021-0248
Effects of 4-Hydroxybenzaldehydeon on Interactions With Neurovascular Unit-Related Cells
Yuan, Y., & Rong, D. (2024) · Acta Poloniae Pharmaceutica - Drug Research · doi:10.32383/appdr/185428
Wang, Y., Shi, X., Wu, L., & Tian, H. (2025) · International Journal of Neuroscience · doi:10.1080/00207454.2025.2545534
Li, M., Li, Y., Zuo, L., Hu, W., & Jiang, T. (2021) · Figshare · doi:10.6084/m9.figshare.14429380
Self-citationChan, Y.-J., Liao, P.-L., Tsai, C.-H., Cheng, Y.-W., Lin, F.-L., Ho, J.-D., Chen, C.-Y., & Li, C.-H. (2021) · Figshare · doi:10.6084/m9.figshare.13550758
Chan, Y.-J., Liao, P.-L., Tsai, C.-H., Cheng, Y.-W., Lin, F.-L., Ho, J.-D., Chen, C.-Y., & Li, C.-H. (2021) · Figshare · doi:10.6084/m9.figshare.13550761
Li, M., Li, Y., Zuo, L., Hu, W., & Jiang, T. (2021) · Figshare · doi:10.6084/m9.figshare.14429383
Self-citationZhao, J., Wang, A., & Li, X. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102479
Wang, C., Cai, L., Gong, Q., Yang, Y., Liang, Y., Niu, X., Wei, L., Liu, Z. H., Wu, S. S., Men, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202501197
Self-citationZhang, J., Wang, P., Li, N., & Gao, Y. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71103
Almusined, M. M., Kakkar, P., Yuldasheva, N. Y., Viswambharan, H., Kakkar, T., & Saha, S. (2026) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2026.09.021
Metadata
- Authors
- Lv, J., Hu, W., Yang, Z., Li, T., Jiang, S., Ma, Z., Chen, F., & Yang, Y.
- Affiliations
- Northwest University (CN)
- Air Force Medical University (CN)
- Tang Du Hospital (CN)
- Corresponding author
- Yang, Yang
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 161
- Pages
- 79-96
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2771763619
- Cited by
- 148
- References
- 179
- Citations by year
- 2026: 7 · 2025: 17 · 2024: 16 · 2023: 13 · 2022: 17 · 2021: 26 · 2020: 23 · 2019: 16 · 2018: 13
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81500263)
- China Postdoctoral Science Foundation (2016T90973, 2015M572681)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- claudin-5, blood-brain barrier, ischemic stroke, tight junction proteins, blood-brain barrier permeability, hemorrhagic transformation, neuroprotection, oxidative stress, neuroinflammation, gene therapy, hormone therapy, receptor-targeted therapy, physiotherapy
- MeSH terms
- Animals, Blood-Brain Barrier, Brain Ischemia, Humans, Tissue Plasminogen Activator, Tight Junctions, Stroke, Claudin-5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
